Key result
Early application of extracorporeal membrane oxygenation successfully treated a patient with myocarditis and shock.
Why the study?
Patients with myocarditis who do not respond to immunosuppressive therapy can rapidly deteriorate to shock, and ECMO can sustain hemodynamic stability.
Case Report (n=1)
Early ECMO can be an effective intervention to sustain hemodynamic stability in patients with myocarditis and shock.
May support ECMO in myocarditis shock; hypothesis-generating and requires prospective trials before practice change.
The current therapy for myocarditis is immunosuppressive therapy. However, in rare cases in which patients do not respond to intervention, their condition can rapidly deteriorate to myocarditis with shock, which is characterized by extensive and diffuse lymphocyte infiltration in the myocardium. Most cases of myocarditis are caused by virus-mediated damage of cardiomyocytes, and its clinical manifestations are ventricular arrhythmia and hemodynamic disturbances. Extracorporeal membrane oxygenation is an effective intervention, which regulates hemodynamic stability and avoids systemic hypoperfusion. This intervention has been used to sustain hemodynamic stability in patients with myocarditis and shock. We report here early application of extracorporeal membrane oxygenation for successful treatment of a patient with myocarditis and shock.
No takes yet. Share an insight, caveat, or question.
Meng et al. (2021) conducted a case report in Myocarditis with shock (n=1). Extracorporeal membrane oxygenation was evaluated on Successful treatment. Early application of extracorporeal membrane oxygenation successfully treated a patient with myocarditis and shock.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: